{"grounding": "This article reviews evolving legal implications for clinicians and researchers as genomics is used more widely in both the clinic and in translational research, reflecting rapid changes in scientific knowledge as well as the surrounding cultural and political environment. Professionals will face new and changing duties to make or act upon a genetic diagnosis, address direct-to-consumer genetic testing in patient care, consider the health implications of results for patients\u2019 family members, and recontact patients when test results change over time. Professional duties in reproductive genetic testing will need to be recalibrated in response to disruptive changes to reproductive rights in the United States. We also review the debate over who controls the flow of genetic information and who is responsible for its protection, considering the globally influential European Union General Data Protection Regulation and the rapidly evolving data privacy law landscape of the United States.", "generated_text": "The rapid advancement of genomics has introduced a complex array of legal challenges, particularly concerning liability, duty to warn, and data privacy. This paper explores the evolving legal landscape surrounding genomics, highlighting key issues such as the responsibility of healthcare providers to warn patients about potential genetic risks and the legal implications of mishandling sensitive genetic data. We review recent case law and regulatory developments, emphasizing the need for clear guidelines and best practices to mitigate legal risks. The study also discusses the ethical dimensions of these issues, advocating for a balanced approach that protects patient rights while fostering innovation in genomic research and clinical applications. By addressing these legal land mines, stakeholders can navigate the genomics landscape more effectively, ensuring both compliance and ethical integrity.", "label": 1}